Success for first Cancer Congress Update

The 2009 Cancer Congress Update has been hailed a success by clinicians from the worlds of breast, colorectal, lung, prostate and haematological cancer. Created...

Trafford PCT implements Pandemic Manager

A business intelligence solution for planning the NHS flu response has been implemented by Trafford PCT. Pandemic Manager from 21c, based on Microsoft software,...

Nexavar judgement delayed

NICE has agreed to delay its Final Appraisal Determination for Nexavar (sorafenib) for the treatment of advanced hepatocellular carcinoma (HCC), in order to consider...

New approach to breakthrough cancer pain

The EC has approved the first intranasal spray for breakthrough cancer pain, representing a new approach to the treatment of pain in cancer patients....

UK patients are going abroad for treatment

Many private medical patients from the UK are saving over 50% of their healthcare costs by travelling overseas, a new survey has revealed. The...

Urine collection device takes the prize

A new urine collection device for women has been acclaimed as Best Industrial Product and Best of Show at the Design Week Awards. The...

GSK completes acquisition of Stiefel

GSK has completed its acquisition of Stiefel, creating a new world-leading specialist dermatology business with revenues of approximately $1.5 billion. GSK has acquired the...

London to gain 12 new stroke and trauma centres

Patients in London who have suffered a major trauma or stroke will benefit from 12 new emergency care units planned by a joint committee...

Aberdeen hospital gains faster scanner

Aberdeen Royal Infirmary has strengthened its imaging facilities with the installation of a SPECT system from Siemens Healthcare. The Symbia S scanner will enable...

NICE should relax pricing rules, says Kennedy report

NICE should relax its rules on pricing for drugs that offer the most benefits to patients, an independent study has concluded. The proposal forms...

Latest articles

Study by health experts shows that NHS productivity of the NHS has improved

NHS staff praised as productivity grows

A study by health experts has shown that the productivity of the NHS has improved almost two and a half times faster than the...
Oxford PharmaGenesis awarded second Queen's Award for Enterprise

Oxford PharmaGenesis awarded business accolade

Independent HealthScience communications consultancy Oxford PharmaGenesis has been awarded its second Queen’s Award for Enterprise, the UK’s highest accolade for business success. The consultancy was...
Advance in CAR T therapy eliminates side effects

Advance in CAR T therapy eliminates side effects

A new University of Southern California study has found that an advance in CAR T therapy eliminates side effects and produces remissions without toxicity in...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...

Understanding Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurological condition affecting the central nervous system. ‘Sclerosis’ means the scarring or hardening of tiny patches of tissue; it...
final recommendation for ILUMETRI ®▼

NICE publishes final recommendation for ILUMETRI ®▼

NICE has published final recommendation for ILUMETRI ®▼ (Tildrakizumab), as a cost-effective option for adults with moderate-to-severe plaque psoriasis. The National Institute for Health and Care...
Electronic prescribing to help hospitals tackle medication errors

Electronic prescribing to help hospitals tackle medication errors

Patientrack's parent company has entered into a reseller agreement with healthcare software provider Better by Marand to help hospitals tackle medication errors. Patientrack provides...
Seqirus to make entire influenza vaccine production process cell-based

Seqirus to make entire influenza vaccine production process cell-based

Influenza vaccine manufacturer Seqirus is to manufacture its cell-based influenza vaccine (FLUCELVAX® TETRA) using cell-based Candidate Vaccine Viruses (CVVs) for all four strains recommended...